Prologue Medicines
MA - BostonBiotechnology
Focus: Prologue Medicines is a Boston-based biotech specializing in viral-derived biologics across infectious diseases, neurology, gastroenterology, oncology, and ophthalmology. The company operates at mid-cap scale with 51-200 employees and a public listing.
Profile data last refreshed 53m ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
104+59 this month
Hot — 94 jobs added in 30d
Net +59 (94 new, 35 removed). Aggressive expansion phase.
Should You Work at Prologue Medicines?
AI assessmentPrologue represents a speculative mid-stage biotech with intriguing platform focus but opaque pipeline maturity and financial health—suitable for risk-tolerant scientists but risky for those prioritizing visibility.
Why Work Here
- Heavy R&D hiring (28 roles) and strong data science team (16 roles) signal active pipeline development in an emerging viral-biologics platform.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Prologue Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.